SL INVESTMENT
SL investment (SLi) aims at a company with global standards through management by principle and transparency. SLi is a venture capital firm founded in February 2000 and has widely invested in the companies from early to mezzanine stage, in the field of semiconductors, display (AMOLED, LED, LCD), renewable energy, and health care industry. Since its incorporation, SLi has recorded black-ink balances for 12 consecutive years with zero debt and also has successfully dissolved all the five fun... ds with outstanding earning rates. SLi tries to raise the value of venture companies not only by offering funds but by supporting the management omnidirectionally after its investment. Consequently, 31 companies have been successfully listed in KOSDAQ market for 12 years and all the companies have positioned as leading firms in their specific fields.
SL INVESTMENT
Founded:
2000-02-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Euro ASP.NET IIS Sectigo SSL Sectigo Domain SSL Pound Sterling
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-10-05 | N.THING | SL Investment investment in Series B - N.THING | 21 M USD |
| 2021-10-03 | N.THING | SL Investment investment in Series B - N.THING | 13 M USD |
| 2021-02-08 | ImmunoMet Therapeutics | SL Investment investment in Venture Round - ImmunoMet Therapeutics | 7 M USD |
| 2020-11-26 | Agreable | SL Investment investment in Series B - Agreable | 9.5 B KRW |
| 2020-10-22 | Lab n People | SL Investment investment in Series B - Lab n People | 2 B KRW |
| 2018-06-01 | SOS LAB | SL Investment investment in Series A - SOS LAB | 6 M USD |
| 2018-01-05 | Caret Games | SL Investment investment in Venture Round - Caret Games | 28 M USD |
| 2017-07-25 | Urbanbase | SL Investment investment in Series A - Urbanbase | 3.3 M USD |
| 2017-06-01 | Wantedlab | SL Investment investment in Series B - Wantedlab | 8.9 M USD |
| 2017-03-07 | ImmunoMet Therapeutics | SL Investment investment in Series B - ImmunoMet Therapeutics | 5 M USD |